Re: Phase II Trial of Cabozantinib Plus Nivolumab in Patients with Non-clear-cell Renal Cell Carcinoma and Genomic Correlates.
作者信息
Xu Yunze, Huang Yiran, Zhang Jin
机构信息
Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
出版信息
Eur Urol. 2022 Sep;82(3):331-332. doi: 10.1016/j.eururo.2022.04.033. Epub 2022 May 20.
PMID:35599185
Abstract
摘要
Zotero 插件